发明名称 |
Treatment of hepatitis C virus |
摘要 |
A combined therapy which utilizes hydroxychloroquine and GNS-227:;
for the treatment of an HCV-related disease, including HCV chronic infection, is disclosed. Further disclosed is pharmaceutical composition (e.g., as a unit dosage form) comprising hydroxychloroquine and GNS-227. |
申请公布号 |
US8912141(B2) |
申请公布日期 |
2014.12.16 |
申请号 |
US201214128684 |
申请日期 |
2012.06.21 |
申请人 |
Panmed Ltd. |
发明人 |
Halfon Philippe |
分类号 |
A61K31/4706;A61K45/06;A61K38/06;A61K31/405 |
主分类号 |
A61K31/4706 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a hepatitis C virus (HCV) infection in a subject in need thereof, the method comprising co-administering to the subject a therapeutically effective amount of hydroxychloroquine or a pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of the compound GNS-227:thereby treating the HCV infection, wherein said therapeutically effective amount of hydroxychloroquine and said therapeutically effective amount of said GNS-227 are selected such that said hydroxychloroquine and said GNS-227 act in synergy in reducing HCV replication. |
地址 |
Beersel BE |